Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (13 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (19)
COVID-19 (2)
Type
(
1 selected
)
Type
Guidance (872)
Guidance programme
(
11 selected
)
Guidance programme
Antimicrobial prescribing guidelines (18)
Cancer service guidelines (0)
Clinical guidelines (136)
COVID-19 rapid guidelines (2)
Diagnostics guidance (25)
Health technology evaluations (17)
Highly specialised technologies guidance (23)
Interventional procedures guidance (172)
Medical technologies guidance (55)
NICE guidelines (177)
Public health guidelines (14)
Safe staffing guidelines (0)
Social care guidelines (21)
Technology appraisal guidance (422)
Apply filters
Showing 26 to 50 of 872
Sort by
Date
Title
Apply sorting
Last updated date between 1/4/2018 and 28/3/2024
Remove Last updated date between 1/4/2018 and 28/3/2024 filter
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Interventional procedures guidance
Remove Guidance programme: Interventional procedures guidance filter
Guidance programme: Clinical guidelines
Remove Guidance programme: Clinical guidelines filter
Guidance programme: Medical technologies guidance
Remove Guidance programme: Medical technologies guidance filter
Guidance programme: Diagnostics guidance
Remove Guidance programme: Diagnostics guidance filter
Guidance programme: Highly specialised technologies guidance
Remove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Social care guidelines
Remove Guidance programme: Social care guidelines filter
Guidance programme: Antimicrobial prescribing guidelines
Remove Guidance programme: Antimicrobial prescribing guidelines filter
Guidance programme: Public health guidelines
Remove Guidance programme: Public health guidelines filter
Guidance programme: Cancer service guidelines
Remove Guidance programme: Cancer service guidelines filter
Guidance programme: Safe staffing guidelines
Remove Guidance programme: Safe staffing guidelines filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments
TA948
31 January 2024
31 January 2024
Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal)
TA945
30 January 2024
30 January 2024
Caesarean birth
NG192
31 March 2021
30 January 2024
Devices for remote monitoring of Parkinson's disease
DG51
25 January 2023
25 January 2024
Pharyngeal electrical stimulation for neurogenic dysphagia
IPG781
23 January 2024
23 January 2024
Temperature control to improve neurological outcomes after cardiac arrest
IPG782
23 January 2024
23 January 2024
Olaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer
TA946
17 January 2024
17 January 2024
Early and locally advanced breast cancer: diagnosis and management
NG101
18 July 2018
16 January 2024
Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer
TA944
10 January 2024
10 January 2024
Sebelipase alfa for treating Wolman disease
HST30
10 January 2024
10 January 2024
Intravascular lithotripsy for calcified arteries in peripheral arterial disease
IPG780
3 January 2024
3 January 2024
Bipolar disorder: assessment and management
CG185
24 September 2014
21 December 2023
Targeted-release budesonide for treating primary IgA nephropathy
TA937
20 December 2023
20 December 2023
Ravulizumab for treating generalised myasthenia gravis (terminated appraisal)
TA940
20 December 2023
20 December 2023
Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (terminated appraisal)
TA941
20 December 2023
20 December 2023
Empagliflozin for treating chronic kidney disease
TA942
20 December 2023
20 December 2023
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes
TA943
19 December 2023
19 December 2023
Risdiplam for treating spinal muscular atrophy
TA755
16 December 2021
15 December 2023
Middle meningeal artery embolisation for chronic subdural haematomas
IPG779
14 December 2023
14 December 2023
Cardiovascular disease: risk assessment and reduction, including lipid modification
NG238
14 December 2023
14 December 2023
Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer
TA939
13 December 2023
13 December 2023
Velmanase alfa for treating alpha-mannosidosis
HST29
13 December 2023
13 December 2023
Dupilumab for treating eosinophilic oesophagitis in people 12 years and over (terminated appraisal)
TA938
7 December 2023
7 December 2023
Acne vulgaris: management
NG198
25 June 2021
7 December 2023
Secukinumab for treating moderate to severe hidradenitis suppurativa
TA935
6 December 2023
6 December 2023
Previous page
1
Current page
2
3
4
…
35
Page
2
of
35
Next page
Results per page
10
25
50
All
Back to top